Cath Lab Digest - February 2008 - (Page 61)

Defining Best Practices for Contrast Media Use in High-Risk Patients: An Evidence-Based Approach to CIN in Angiography Complimentary Accredited Breakfast Symposium March 31, 2008 5:30 am – 7:00 am Hyatt Regency Chicago 151 East Wacker Drive Chicago, IL 60601 Regency Ballroom A Please visit www.naccme.com to register. Faculty: Moderator Jonathan S. Reiner, MD Professor of Medicine Director, Cardiac Catheterization Laboratory George Washington University Medical Center Washington, DC Agenda: 5:30 am – 6:00 am Registration/Breakfast Roxana Mehran, MD Associate Professor of Medicine Columbia University Medical Center Director of Outcomes Research Data Coordination and Analysis Center for Interventional Vascular Therapies Cardiovascular Research Foundation New York, NY 6:00 am – 6:05 am Welcome Jonathan S. Reiner, MD 6:05 am – 6:20 am CIN: The High-Risk Patient Roxana Mehran, MD Richard Solomon, MD Chief, Division of Nephrology Fletcher Allen Health Care Newport, VT 6:20 am – 6:35 am Contrast Media Safety in Angiography: The CARE Study Jonathan S. Reiner, MD 6:35 am – 6:50 am Learning Objectives: Upon completion of this educational activity, participants should be able to: Reducing Risk in Patients with Renal Impairment Undergoing Cardiac Angiography Richard Solomon, MD • Discuss the diagnosis and prevention of CIN. • Properly identify high-risk patients. • Review recent contrast media safety data. Target Audience: Physicians and nurses who treat high-risk patients. Accreditation 6:50 am – 7:00 am Q&A MD/DO: This activity is sponsored by the North American Center for Continuing Medical Education (NACCME). NACCME is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. NACCME designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity. This activity has been planned and produced in accordance with the ACCME Essential Areas and Policies. Nurses: ANCC: NACCME is an approved provider of continuing nursing education by the Pennsylvania State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. This continuing nursing education activity was approved by the PA State Nurses Association for 1 contact hour (Provider Number 110-3-E-06). Provider approved by the California Board of Registered Nursing, Provider Number 13255, for 1 contact hour. Faculty Disclosures: Faculty and all others who have the ability to control the content of continuing medical education activities sponsored by NACCME are expected to disclose whether they do or do not have any real or apparent conflicts of interest or other relationships related to the content of their presentations. It is not assumed that these financial interests or affiliations will have an adverse impact on faculty presentations. All those involved in the planning and editing of this educational activity have disclosed that they have no significant financial relationship with any organization that could be perceived as a real or apparent conflict of interest in the context of this educational activity. This activity is supported by an educational grant from Bracco Diagnostics Inc. This activity is sponsored by the North American Center for Continuing Medical Education.This event is not part of the official ACC Annual Scientific Session as planned by the Annual Scientific Session Program Committee (ASSPC) and/or the SCAI Annual Scientific Sessions in Partnership with ACC i2 Summit Program Committee. This event is not part of the official ACC Annual Scientific Session and/or the SCAI Annual Scientific Sessions in Partnership with ACC i2 Summit as planned by their Program Committees. http://www.naccme.com http://www.naccme.com

Table of Contents Feed for the Digital Edition of Cath Lab Digest - February 2008

Cath Lab Digest - February 2008 Bay Regional Medical Center ENDEAVOR IV: A Zotarolimus-Eluting Stent Versus a Paclitaxel-Eluting Stent in a Randomized Clinical Trial A 3D CT Vessel “Roadmap” Over Live Fluoroscopy for Chronic Total Occlusions Contents Clinical Editor’s Corner An Evaluation of Cath Lab Turnaround Time Commentary: An Evaluation of Cath Lab Turnaround Time Excerpts from Chapter 19. STEMI Interventions – Future Perspectives The Potential Clinical Utility of Intravascular Ultrasound Guidance in Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents The Ten-Minute Interview with…Debbie Charlton, RN The Society of Invasive Cardiovascular Professionals (SICP) at Transcatheter Cardiovascular Therapeutics (TCT) 2007 The Cath Lab is a Business: Do You Have the Knowledge to Stay Afloat? Incidence and Predictors of Vascular Complications after Invasive Coronary Procedures: A Prospective Analysis Ask the Clinical Instructor: A Q&A Column for those New to the Cath Lab Volunteer Survey SICP* Section Meetings Calendar What Do You Think? CEU Education Center Clinical & Industry News Classifieds Advertisers Index

Cath Lab Digest - February 2008

For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.